The mechanisms by which mammary
carcinomas acquire
hormone independence are still unknown. To study the role of cancer-associated fibroblasts (CAF) in the acquisition of
hormone-independence we used a
hormone-dependent (HD) mouse mammary
tumor and its
hormone-independent (HI) variant, which grows in vivo without
hormone supply. HI
tumors express higher levels of FGFR-2 than HD
tumors. In spite of their in vivo differences, both
tumors have the same
hormone requirement in primary cultures. We demonstrated that CAF from HI
tumors (CAF-HI) growing in vitro, express higher levels of
FGF-2 than HD counterparts (CAF-HD).
FGF-2 activated the
progesterone receptors (PR) in the
tumor cells, thus increasing cell proliferation in both HI and HD
tumors. CAF-HI induced a higher proliferative rate on the
tumor cells and in PR activation than CAF-HD. The blockage of
FGF-2 in the co-cultures or the genetic or pharmacological inhibition of FGFR-2 inhibited PR activation and
tumor cell proliferation. Moreover, in vivo, the FGFR inhibitor decreased C4-HI
tumor growth, whereas
FGF-2 was able to stimulate C4-HD
tumor growth as MPA. T47D human
breast cancer cells were also stimulated by
progestins,
FGF-2 or CAF-HI, and this stimulation was abrogated by antiprogestins, suggesting that the murine C4-HI cells respond as the human T47D cells. In summary, this is the first study reporting differences between CAF from HD and HI
tumors suggesting that CAF-HI actively participate in driving HI
tumor growth.